Suppr超能文献

抗氧化剂在新冠肺炎肺炎中的免疫增强和抗病毒作用:治疗视角

Immune-Boosting and Antiviral Effects of Antioxidants in COVID-19 Pneumonia: A Therapeutic Perspective.

作者信息

Sanduzzi Zamparelli Stefano, Sanduzzi Zamparelli Alessandro, Bocchino Marialuisa

机构信息

Division of Pneumology and Semi-Intensive Respiratory Therapy, A. Cardarelli Hospital, 80131 Naples, Italy.

Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80131 Naples, Italy.

出版信息

Life (Basel). 2025 Jan 16;15(1):113. doi: 10.3390/life15010113.

Abstract

The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has profoundly impacted global health, with pneumonia emerging as a major complication in severe cases. The pathogenesis of COVID-19 is marked by the overproduction of reactive oxygen species (ROS) and an excessive inflammatory response, resulting in oxidative stress and significant tissue damage, particularly in the respiratory system. Antioxidants have garnered considerable attention for their potential role in managing COVID-19 pneumonia by mitigating oxidative stress and modulating immune responses. This review provides a comprehensive overview of the literature on the use of antioxidants in hospitalized patients with mild-to-moderate COVID-19. Studies exploring antioxidants, including vitamins, trace elements, nitric oxide (NO), ozone (O), glutathione (GSH), L-carnitine, melatonin, bromelain, N-acetylcysteine (NAC), and numerous polyphenols, have yielded promising outcomes. Through their ROS-scavenging properties, these molecules support endothelial function, reduce the thrombosis risk, and may help mitigate the effects of the cytokine storm, a key contributor to COVID-19 morbidity and mortality. Clinical evidence suggests that antioxidant supplementation may improve patient outcomes by decreasing inflammation, supporting immune cell function, and potentially shortening recovery times. Furthermore, these molecules may mitigate the symptoms of COVID-19 by exerting direct antiviral effects that inhibit the infection process and genomic replication of SARS-CoV-2 in host cells. Moreover, antioxidants may work synergistically with standard antiviral treatments to reduce viral-induced oxidative damage. By integrating findings from the literature with real-world data from our clinical experience, we gain a more profound understanding of the role of antioxidants in managing COVID-19 pneumonia. Further research combining comprehensive literature reviews with real-world data analysis is crucial to validate the efficacy of antioxidants and establish evidence-based guidelines for their use in clinical practice.

摘要

由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的2019冠状病毒病大流行对全球健康产生了深远影响,肺炎成为重症病例的主要并发症。2019冠状病毒病的发病机制以活性氧(ROS)过度产生和过度炎症反应为特征,导致氧化应激和显著的组织损伤,尤其是在呼吸系统。抗氧化剂因其在减轻氧化应激和调节免疫反应以管理2019冠状病毒病肺炎方面的潜在作用而备受关注。本综述全面概述了关于在轻度至中度2019冠状病毒病住院患者中使用抗氧化剂的文献。探索抗氧化剂的研究,包括维生素、微量元素、一氧化氮(NO)、臭氧(O)、谷胱甘肽(GSH)、左旋肉碱、褪黑素、菠萝蛋白酶、N-乙酰半胱氨酸(NAC)以及众多多酚,已取得了有前景的结果。通过其清除ROS的特性,这些分子支持内皮功能,降低血栓形成风险,并可能有助于减轻细胞因子风暴的影响,细胞因子风暴是2019冠状病毒病发病和死亡的关键因素。临床证据表明,补充抗氧化剂可能通过减轻炎症、支持免疫细胞功能并可能缩短恢复时间来改善患者预后。此外,这些分子可能通过发挥直接抗病毒作用来减轻2019冠状病毒病的症状,这种作用可抑制宿主细胞中SARS-CoV-2的感染过程和基因组复制。此外,抗氧化剂可能与标准抗病毒治疗协同作用,以减少病毒诱导的氧化损伤。通过将文献研究结果与我们临床经验中的实际数据相结合,我们对抗氧化剂在管理2019冠状病毒病肺炎中的作用有了更深刻的理解。将全面的文献综述与实际数据分析相结合的进一步研究对于验证抗氧化剂的疗效并建立其在临床实践中使用的循证指南至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b105/11766556/277b5fecaac0/life-15-00113-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验